News

Evaluating Amazon.com and Its Broadline Retail Competitors

Evaluating Amazon.com and Its Broadline Retail Competitors

Understanding Amazon.com in the Retail Market

In today's ever-evolving business arena, it is crucial for investors and enthusiasts to scrutinize leading companies actively. This analysis focuses on Amazon.com (NASDAQ: AMZN) and its standing against prominent players in the Broadline Retail sector. By diving into essential financial indicators, market positioning, and prospects for growth, we offer valuable insights that clarify where Amazon stands in the competitive landscape.

Amazon.com Overview

Amazon has established itself as the premier online retailer and marketplace, catering to third-party sellers alongside its vast suite of services. The retail segment generates approximately 75% of its total revenue, supplemented by around 15% from Amazon Web Services (AWS), while advertising contributes about 5% to 10%, with the remainder falling under various categories. The company’s international segments account for 25% to 30% of non-AWS sales, primarily coming from markets such as Germany, the United Kingdom, and Japan.

Financial Metrics Compared to Peers

When evaluating Amazon's financial health, key metrics reveal how it stacks up against its industry contemporaries. For instance:

Average Financial Performance Indicators

According to the most recent data, Amazon’s Price to Earnings (P/E) ratio stands at 34.75, considerably above the industry average of 34.13. This higher valuation indicates that investors are willing to pay a premium for Amazon’s earnings compared to its peers.

P/B, P/S Ratios, and ROE

Assessing Price to Book (P/B) and Price to Sales (P/S) ratios gives additional insight. Amazon's P/B ratio is at 7.28, which exceeds the industry average by 1.31x, possibly suggesting overvaluation based on its book value. Meanwhile, the P/S ratio of 3.67 indicates that the stock might also be mispriced concerning its sales performance against competitors.

Operational Performance

Amazon's Return on Equity (ROE) is noteworthy at 5.68%, higher than the industry average, underscoring the company’s effective use of equity in generating profits.

Profitability and Growth Trajectories

Impressive EBITDA and Gross Profit

Amazon showcases a powerful Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $36.6 billion, which surpasses the industry average by a significant margin. Likewise, with $86.89 billion in gross profit, Amazon demonstrates superior profitability capabilities compared to its counterparts.

Robust Revenue Growth

Additionally, Amazon's revenue growth rate of 13.33% outpaces the industry's average of 8.8%, indicating strong momentum and market share acquisition.

Debt Levels and Financial Resilience

Debt to Equity Analysis

The Debt to Equity (D/E) ratio is another vital metric to gauge financial health. Amazon holds a D/E ratio of 0.4, significantly lower than many of its top competitors, reflecting a conservative approach to leveraging debt and indicating a robust balance between debt and equity—a trait valued by investors.

Conclusion and Strategic Insights

To summarize, Amazon.com’s high P/E, P/B, and P/S ratios hint at a possibly overvalued stock when assessed against peers within the Broadline Retail industry. However, the company's impressive ROE, EBITDA, gross profit, and revenue growth highlight its operational strength and growth potential. Investors must weigh both the valuation insights and operational indicators when considering positions in Amazon.com versus its competitors. Keeping the focus on strategic performance while navigating the stock landscape allows for informed decision-making aligned with investment objectives.

Frequently Asked Questions

What is the primary source of revenue for Amazon.com?

The primary source of revenue for Amazon.com comes from its retail operations, which account for approximately 75% of its total sales.

How does Amazon's P/E ratio compare to the industry?

Amazon's P/E ratio of 34.75 is higher than the industry average of 34.13, suggesting that investors are valuing the stock higher than its competitors.

What does a higher ROE indicate about Amazon's performance?

A higher ROE indicates that Amazon is effectively using its equity to generate profits, which is a positive signal for investors regarding company performance.

What is Amazon's EBITDA and why is it important?

Amazon's EBITDA is $36.6 billion, which is crucial as it reflects the company's operational profitability and cash flow generation without the impact of financial and accounting decisions.

Why is the Debt to Equity ratio significant for investors?

The Debt to Equity ratio is significant as it helps investors understand how much debt the company is using to finance its operations, indicating financial stability and risk level.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading